Inhibition of RPS15A by miR-519d-3p leads to the down-regulation of Wnt/β-catenin pathway in pancreatic cancer which proves the potential role of RPS15A as a target to treat pancreatic cancer [101]. Here, RPS15A is linked to familial pancreatic carcinoma.